Salvage therapies of autoimmune hepatitis limit proinflammatory immune cells while sparing regulatory T cells

Autoimmune hepatitis (AIH) can be clinically controlled by first-line immunosuppressive therapy in the majority of patients. However, a selective decrease in intrahepatic regulatory T cells (Treg) was observed with immunosuppressive therapy, which was even more pronounced in patients with incomplete...

Descripción completa

Detalles Bibliográficos
Autores principales: Derben, Finn C., Ytting, Henriette, Hartleben, Björn, Bantel, Heike, Wedemeyer, Heiner, Willemoe, Gro L., Jaeckel, Elmar, Taubert, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043582/
https://www.ncbi.nlm.nih.gov/pubmed/36976659
http://dx.doi.org/10.1097/HC9.0000000000000088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043582/
https://www.ncbi.nlm.nih.gov/pubmed/36976659
http://dx.doi.org/10.1097/HC9.0000000000000088

Ejemplares similares